Gujarat Themis Biosyn Ltd Sustainability Reports
Gujarat Themis Biosyn Ltd. manufactures and sells fermentation-based Active Pharmaceutical Ingredients (APIs) and drug intermediates. Its key products include Rifamycin-S and Rifamycin-O, which serve as essential intermediates for anti-tuberculosis treatments.
Sector: Manufacturing
Country: India
Exchange: Bombay Stock Exchange
LEI: 3358009IT99XRO254Q79
16 reports from 2009 to 2025
